Global Lipid Market

The edible films and coatings market consists of sales of edible films and coatings and related products by entities (organizations, sole traders, and partnerships) used for preventing moisture loss, maintaining quality, safe transportation, and storage of foods. Edible films and coatings refer to thin layers of edible materials applied to food products that play an important role in their conservation, distribution, and marketing. The main types of ingredients in edible films and coatings are protein, polysaccharides, lipids, and composites. Proteins refer to a class of nitrogenous organic compounds that have large molecules composed of one or more long chains of amino acids. The applications include dairy products, bakery and confectionery, fruits and vegetables, meat, poultry, seafood, and other applications. The various end-users include food and beverages and pharmaceuticals. The edible films and coatings market research report is one of a series of new reports from The Business Research Company that provides edible films and coatings market statistics, including edible films and coatings industry global market size, regional shares, competitors with an edible films and coatings market share, detailed edible films and coatings market segments, market trends and opportunities, and any further data you may need to thrive in the edible films and coatings industry. This edible films and coatings market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global edible films and coatings market size grew from $2.95 billion in 2022 to $3.2 billion in 2023 at a compound annual growth rate (CAGR) of 8.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services, and affecting many markets across the globe. The edible films and coatings market size is expected to grow to $4.25 billion in 2027 at a CAGR of 7.4%. The increase in the sales of fruits and vegetables across the globe is expected to propel the growth of the edible films and coating market going forward. Fruits and vegetables are the sources of food that are obtained from plants. Edible films and coatings are used for the packing of fruits and vegetables as they increase the shelf life and are eco-friendly. According to a report by FreshPlaza, a Netherlands-based media platform for the fresh produce industry, the sale of organic fresh produce reached $2.3 billion in the first quarter of 2022, an increase of 4% from previous years. This increase in the sales of fruits and vegetables across the globe is driving the edible film and coating market. Technological advancement is a key trend gaining popularity in the edible films and coatings market. Major companies operating in the edible films and coatings market are focusing on product innovation with innovative technologies to strengthen their position in the edible films and coatings market. For instance, in April 2021, AgroFresh Solutions Inc., a US-based food freshness and quality solutions provider, launched a new plant-based film called VitaFresh Botanicals – Life Ultra that uses a new innovative technology involving a nanoemulsion process that generates smaller particles, thereby offering a superior coating of foods and more protection. This product ensures the freshness of the product, reduces dehydration and reduces the food loss reduction for certain tropical fruits. In November 2022, Sherwin-Williams Company, a US-based company manufacturer of paint and coatings, reached an agreement to purchase Peter Möhrle Holding and the GP Capital UG partnership, which included Oskar Nolte GmbH and Klumpp Coatings GmbH for an undisclosed amount. With this acquisition, Sherwin-Williams is expected to develop profitably faster in the worldwide industrial wood market and continues to follow its acquisition strategy of complementary, superior, and differentiating companies. Oskar Nolte GmbH is a Germany-based producer and distributor of industrial coating products. The major players in the edible films and coatings market are Tate & Lyle PLC, DuPont de Nemours Inc., Dohler Group, Koninklijke DSM NV, Cargill Incorporated, Ingredion Incorporated, Watson Inc., Kerry Group PLC, Ashland Inc., JRF Technology LLC, BluWrap, CP Kelco, Nagase & Co. Ltd., FMC Corporation, and MonoSol LLC. North America was the largest region in the edible films and coatings market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this edible films and coatings market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the edible films and coatings market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The edible films and coatings market consists of sales of protein-based coatings such as collagen films, gelatin films and wheat gluten films. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global edible films and coatings market is segmented - 1) By Ingredient Type: Protein, Polysaccharides, Lipids, Composites 2) By Application: Dairy products, Bakery and Confectionery, Fruits and Vegetables, Meat, Poultry, and Seafood, Other Applications 3) By End-User: Food and Beverage, Pharmaceuticals

Nutritional analysis is the process of estimating the calorie, macronutrient, and micronutrient content of a meal and also helps in the detailed and perfect determination of the component nutrients present in any food item. Completing a nutritional analysis of the food manufactured or sold helps to ensure its compliance with various national and international regulations. The main nutritional analysis parameters include vitamin profile, mineral profile, total dietary fiber, fat profile, sugar profile, calories, cholesterol, moisture, and other parameters. The vitamin profile is used to monitor and analyze the levels of vitamins in different food products. The different nutritional analysis product types include beverages, snacks, bakery and confectionery, meat and poultry, sauces, dressings, and condiments, dairy and desserts, fruits and vegetables, edible fats and oils, baby foods, and other products types. The objectives of nutritional analysis are new product development, product labeling, and regulatory compliance. The nutritional analysis market research report is one of a series of new reports from The Business Research Company that provides nutritional analysis market statistics, including global market size, regional shares, competitors with nutritional analysis market share, detailed nutritional analysis market segments, market trends and opportunities, and any further data you may need to thrive in the nutritional analysis industry. This nutritional analysis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global nutritional analysis market size grew from $5.31 billion in 2022 to $5.75 billion in 2023 at a compound annual growth rate (CAGR) of 8.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The nutritional analysis market size is expected to grow to $7.99 billion in 2027 at a CAGR of 8.6%. The increasing consumer awareness and change in preference for consuming healthy food are expected to propel the growth of the nutritional analysis market. Nutritional analysis helps to understand the chemical composition, processing, quality control, and contamination of food, thus ensuring a good and healthy intake of food. A healthy diet helps to protect against malnutrition in all its forms and also protects against non-communicable diseases (NCDs), including heart disease, diabetes, stroke, and cancer. For instance, according to the International Food Information Council's (IFIC) 2020 food and health survey, Americans have a strong interest in becoming more health-conscious, with 43% following a specific diet or eating pattern in 2020, up 38% compared to the previous year. Therefore, the increasing consumer awareness and change in preference for consuming healthy food are driving the growth of the nutritional analysis market. Technological advancements are a key trend gaining popularity in the nutritional analysis market. Stakeholders in the market are focusing on developing equipment and platforms that enable better tracking and analysis of nutritional content. For instance, in 2020, the Sanku-Project Healthy Children developed a dosifier technology to enable small flour mills in East Africa to fortify flour with a precise amount of nutrients. The dosifier manages and adds essential nutrients during the flour milling process. The technology is capable of giving precise amounts of nutrients to each bag of flour, with reduced costs. The addition of cellular connectivity enables real-time information on maintenance, machine tracking, nutrient content, and performance. In July 2021, a US-based private equity firm Warburg Pincus acquired Food Safety Net Services for an undisclosed amount. Through this acquisition, Warburg consolidated its position as a leading North American platform provider of testing and regulatory consulting services. Food Safety Net Services is a US-based biotechnology firm providing microbiological and chemical analysis. Major players in the nutritional analysis market are SGS SA, Intertek Group plc, Eurofins Scientific, Bureau Veritas, ALS Limited, Mérieux NutriSciences Corporation, Thermo Fisher Scientific Inc., AsureQuality services, TÜV NORD GROUP, Dairy Technical Services Limited, QIAGEN, Covance., AWTA Ltd., Microbac Laboratories, Inc., Food Lab, Inc., NutriData, MenuSano, Nutritional Information Solutions, Nettnutrition, Food Consulting Company, Gujarat Laboratories and Opal Research and Analytical Services North America was the largest region in the nutritional analysis market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nutritional analysis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the nutritional analysis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The nutritional analysis market includes revenues earned by entities by providing products and services used to determine the nutritional content of foods and food products. Nutritional analysis is used to analyze the nutritional content present in food products and understand the chemical composition, processing, quality control, and contamination of food. The nutritional information includes a range of information such as calories, vitamins, and minerals, thus allowing consumers to make informed purchases. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global nutritional analysis market is segmented - 1) By Parameter: Vitamin Profile, Mineral Profile, Total Dietary Fiber, Fat Profile, Sugar Profile, Calories, Cholesterol, Moisture, Other Parameters 2) By Product Type: Beverages, Snacks, Bakery and Confectionery, Meat and Poultry, Sauces, Dressings, and Condiments, Dairy and Desserts, Fruits and Vegetables, Edible Fats and Oils, Baby Foods, Other Product Types 3) By Objective: New Product Development, Product Labeling, Regulatory Compliance

Parenteral nutrition refers to injecting a certain type of food through a vein as described in medicine (intravenously). Malnutrition correction or prevention is the aim of the therapy. It denotes intravenous feeding (through a vein). Achieving balance nutritional intake on time can help combat complications and plays a prominent role in a patient’s recovery. The main compositions used in parenteral nutrition include amino acids, fats, carbohydrates, trace elements, vitamins, minerals, and other compositions. Amino acids-based parenteral nutrition refers to parenteral nutrition products comprised sourced from amino acids. Amino acids are a standard component of complete parenteral nutrition prescriptions to support cell, organ, skeletal, and respiratory muscle functions, and wound healing. They are used for adults, children, and newborns in hospitals, clinics, home care, and other end-users. The parenteral nutrition market research report is one of a series of new reports from The Business Research Company that provides parenteral nutrition market statistics, including parenteral nutrition industry global market size, regional shares, competitors with a parenteral nutrition market share, detailed parenteral nutrition market segments, market trends and opportunities, and any further data you may need to thrive in the parenteral nutrition industry. This parenteral nutrition market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global parenteral nutrition market size grew from $6.35 billion in 2022 to $6.84 billion in 2023 at a compound annual growth rate (CAGR) of 7.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The parenteral nutrition market size is expected to grow to $9.24 billion in 2027 at a CAGR of 7.8%. The growing prevalence of malnutrition across the globe is driving the growth of the parenteral nutrition market. Malnutrition refers to deficiencies, excesses, or imbalances in a person’s intake of energy or nutrients. Premature births, which result in immune dysfunction and inadequate nutrition, have increased the demand for and use of parenteral nutrition among children and infants. For instance, in July 2022, the United Nations Food and Agriculture Organization (FAO) reported that around 46 million more people were impacted by hunger in 2020 than in 2020, and 150 million more since the COVID-19 pandemic epidemic, bringing the total number of hungry people on the planet to 828 million in 2021. Hence, the growing prevalence of malnutrition across the globe is expected to boost demand for parenteral nutrition during the forecast period. The strategic partnership is a key trend gaining popularity in the parenteral nutrition market. Key healthcare players, associations, and researchers are focusing on entering into strategic partnerships to research, develop, launch, or create awareness of the use of parenteral nutrition containing new ingredients such as omega-3 fatty acids. These partnerships help to educate health care professionals and companies to develop and market their products, strengthening their market position. For instance, in November 2020, the American Society for Parenteral and Enteral Nutrition (ASPEN), a US-based professional organization partnered with Fresenius Kabi, a Germany-based global healthcare company to create the key expert interview series on omega-3 fatty acid-containing parenteral nutrition to support continuous health care professional (HCP) education on omega-3 fatty acids in clinical nutrition. In October 2021, Wellspring Capital Management, a New York-based private equity company acquired Pentec Health Inc., a US-based provider of intradialytic parenteral nutrition and targeted drug delivery therapies for an undisclosed amount. The acquisition by Wellspring is focused on strengthening its position in the specialty infusion sector and accelerating its inorganic & organic growth campaigns. Major players in the parenteral nutrition market are Baxter International, Vifor Pharma, Grifols SA, Otsuka Pharmaceutical Co. Ltd., Fresenius Kabi, B. Braun Melsungen AG, Pfizer Inc., Sichuan Kelun Pharmaceutical Co. Ltd., Claris Lifesciences Limited, SGD Pharma, ICU Medical, and Soleo Health. North America was the largest region in the parenteral nutrition market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the parenteral nutrition market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the parenteral nutrition market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The parenteral nutrition market includes revenues earned by entities by infusing a specialized form of food through a vein. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced.It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global parenteral nutrition market is segmented - 1) By Composition: Amino Acids, Fats, Carbohydrates, Trace Elements, Vitamins, Minerals, Other Compositions 2) By Consumer Type: Children and New-born, Adults 3) By End-User: Hospitals, Clinics, Homecare, Other End Users

Hypolipidemic drugs refer to any substance that lowers the blood's concentration of lipids and lipoproteins (lipid-protein complexes). Lipoproteins can build up in blood arteries and bind cholesterol. Its alternate name is "lipid-lowering medication", The main product types of hypolipidemic drugs are cholic acid regulators, HMG-CoA reductase inhibitors, adenylate cyclase inhibitors, nicotinic acid drugs, and others. HMG-CoA reductase inhibitors are lipid-lowering drugs used in the primary and secondary prevention of coronary heart disease. The drugs are used by hospitals, clinics, pharmacies, and cardiovasology. The different types of drugs include statins, bile acid sequestrants, cholesterol absorption inhibitors, PCSK9 inhibitors, and others. The hypolipidemic drugs market research report is one of a series of new reports from The Business Research Company that provides hypolipidemic drugs market statistics, including hypolipidemic drugs industry global market size, regional shares, competitors with a hypolipidemic drugs market share, detailed hypolipidemic drugs market segments, market trends and opportunities, and any further data you may need to thrive in the hypolipidemic drugs industry. This hypolipidemic drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global hypolipidemics market size will grow from $30.39 billion in 2022 to $31.79 billion in 2023 at a compound annual growth rate (CAGR) of 4.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global hypolipidemics market size is expected to grow to $35.75 billion in 2027 at a CAGR of 3.0%. Shifts in diet and changes in lifestyles of people are driving the growth of the hypolipidemic drugs market. An increase in the consumption of unhealthy food, and the rising prevalence of smoking and drinking have led to an increase in the level of cholesterol intake in people. For instance, in June 2021, according to the World Health Organization data 2021, a Switzerland-based Government agency responsible for international public health, cardiovascular diseases (CVDs) are the leading cause of death globally, taking an estimated 17.9 million lives each year. The rising levels of cholesterol due to changes in lifestyles of the people is rising demand for hypolipidemic drugs as they aid in lowering the cholesterol levels. The growth in the usage of biologics acts as a prime restraint that hinders the hypolipidemic drug market growth. Biologics are derived from living organisms like human beings, animals, and microorganisms, different from chemical drugs or chemically synthesized drugs. The increasing preference towards hypolipidemic biologic medicines due to side effects concerns of using chemically synthesized drugs leads to a decrease in the sales of traditional hypolipidemic chemical drugs and hence, hindering the hypolipidemic drug (chemical) market growth. According to Harvard Medical School, 10%-29% of people who consume hypolipidemic drugs such as cholesterol-lowering statin drugs are suffering from muscle pains and aches. For instance, PCSK9 Inhibitors have been in use since 2015, to reduce LDL cholesterol. Amgens’ Repatha, a hypolipidemic biologic medicine, got FDA approval for the treatment of hypolipidemia. Companies in this market are increasingly investing in using data generated from wearables in clinical trials to improve the speed, and efficiency of trials, and therefore reduce overall costs. By continuously capturing data from patients via wearable technologies, clinical trial sponsors may be able to reduce the burden of frequent site visits, which could improve patient dropout rates and overall clinical trial efficiencies. The use of wearables helps to tackle the challenge of patient recruitment, helps in monitoring patients, gives accurate and real-time data, and gives earlier decision-making opportunities, while the patient is undergoing a clinical trial. Pharmaceutical companies such as Sanofi and Pfizer have already invested in wearable technology to treat hypolipidemia. The EU agencies take 6 to 12 months to approve the hypolipidemic drugs. Moreover, it requires all parts of the registration dossier to be submitted together, unlike the US-FDA, which accepts phased submissions. The US-FDA evaluates each technical section in six months, which may be extended if questions or concerns are raised.However, the technical sections’ assessment is done simultaneously, and therefore the manufacturers should identify the steps that take time, plan the work accordingly, and chalk out an estimated date of approval. Also, the licence validity and renewal of the application in the EU region take a toll on the manufacturer and add to the existing regulatory burden. Therefore, the manufacturer of hypolipidemic drugs should plan well, and communicate effectively to minimise costs and reduce timelines. Major players in the hypolipidemic drugs market are Abbott Laboratories Limited, Apotex Fermentation Inc., Biocon Limited, Cadila Healthcare Limited, Chunghwa Chem Syn& Biotech Co. Ltd., Concord Biotech Limited, Croda Europe Limited Leek, Daiichi Sankyo Company Limited, Dr. Reddy’s Laboratories Ltd., DSM Sinochem Pharma India, Hikal, Ipca Laboratories, Lek Pharmaceuticals d.d., Lupin Limited, Merck Sharp & Dohme B.V., Mylan N.V., Nexchem Pharmaceutical Co. Ltd. CN, Olon S.p.A., Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd., Zhejiang Jiangbei Pharma Co. Ltd CN., MoehsIberica S.L. ES, Pfizer Inc., Recordati S.p.A. IT Milano, AstraZeneca, Amgen, Daiichi Sankyo, Kowa Company Ltd., Sanofi, and Novartis. North America was the largest region in the hypolipidemic drugs market in 2022. The Middle East is expected to be the largest growing region in the global hypolipidemics market during the forecast period. The regions covered in the global hypolipidemic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the hypolipidemic drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA. The hypolipidemic drugs market consists of sales of cholesterol absorption inhibitors, bile acid sequestrants, and fibric acid derivatives. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global hypolipidemics market is segmented - 1) By Product Type: Cholic Acid Regulator, HMG-CoA Reductase Inhibitors, Adenylate Cyclase Inhibitors, Nicotinic Acid Drugs, Other Types 2) By Drug Type: Statins, Bile Acid Sequestrants, Cholesterol Absorption Inhibitors, PCSK9 Inhibitors, Other Drug Types 3) By Application: Hospital, Clinics, Pharmacy, Cardiovasology

The food encapsulation technique is used for incorporating food ingredients, cells, enzymes, and certain other materials into small capsules as the encapsulated materials are protected from heat, moisture, or other extreme condition. Food encapsulation is used to mask taste, color, flavor, and odor, and enhance the viability and stability of the food product. The main food encapsulation technologies include micro encapsulation, nano encapsulation, hybrid technology, and macro encapsulation. Microencapsulation is the process of reducing the volatility, adverse aroma, and reactivity of food products. When exposed to heat, light, moisture, or other adverse conditions, it offers greater stability to food products. The different shell materials in food encapsulation are polysaccharides, proteins, lipids, emulsifiers, and other shell materials. The different food encapsulation core phases are minerals, organic acids, vitamins, enzymes, probiotics, additives, essential oils, prebiotics, and other substances, which are used for applications in dietary supplements, functional food products, bakery products, confectionery, beverages, dairy products, and other applications. The food encapsulation market research report is one of a series of new reports from The Business Research Company that provides food encapsulation market statistics, including food encapsulation industry global market size, regional shares, competitors with food encapsulation market share, detailed food encapsulation market segments, market trends and opportunities, and any further data you may need to thrive in the food encapsulation industry. This food encapsulation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global food encapsulation market size grew from $36.64 billion in 2022 to $39.18 billion in 2023 at a compound annual growth rate (CAGR) of 6.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services, and affecting many markets across the globe. The food encapsulation market size is expected to grow to $50.68 billion in 2027 at a CAGR of 6.6%. The rising demand for fortified and functional foods is expected to propel the growth of the food encapsulation market. Fortified food has added nutrients that do not occur in the food naturally. Functional food reduces the risk of disease and promotes optimal health beyond basic nutrition. Fortified and functional foods are widely used in the food encapsulation market, as they offer added nutrients or healthy ingredients. For instance, in 2020, Switzerland-based food and beverage processing company, Nestle, delivered 196.6 billion fortified servings of food and beverages through their popular brands, including Bear Brand, Cerevita, and Maggi. Technological advancement is a key trend gaining popularity in the food encapsulation market. Technological advancement is the discovery of knowledge that advances technology. For instance, in February 2022, Givaudan, a Switzerland-based manufacturer of food and flavors, launched PrimeLock+, a breakthrough fat encapsulation technology that reduces 30% of the calories and 75% of the fat content in meat substitutes. The innovation in fat encapsulation also offers increased authenticity and flavor stabilization, which allows companies to create tastier, lower-fat, plant-based products such as burgers, sausages, and meatballs while improving the eating experience. In February 2021, International Flavors & Fragrances, Inc. (IFF), a US-based producer of value-added ingredients, merged with the Nutrition and Biosciences Business of DuPont for a deal amount of $7.3 billion. Through this merger, IFF aims to create ingredients and solutions across a wide range of end-markets, including food and beverage, health and wellness, and home and personal care. DuPont Nutrition Biosciences is a Denmark-based developer and producer of food and beverage ingredients, enzymes, and bio-based solutions that also provides food encapsulation solutions. Major players in the food encapsulation market are Cargill, Incorporated, DuPont, Royal DSM, FrieslandCampina, Kerry, International Flavors & Fragrances Inc., Symrise, Balchem Inc., Firmenich SA, Advanced Bionutrition Corp, Aveka, Lycored, Encpasys LLC, Blue California, FierslandCampina, Kievit, Coating Place Inc., Vitablend, Clextral, Tastetech, and Givaudan North America was the largest region in the food encapsulation market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the food encapsulation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the food encapsulation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The food encapsulation market consists of sales of microencapsulation, nanoencapsulation, hybrid technology, and macro encapsulation. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global food encapsulation market is segmented - 1) By Technology: Micro Encapsulation, Nano Encapsulation, Hybrid Technology, Macro Encapsulation 2) By Shell Material: Polysaccharides, Proteins, Lipids, Emulsifiers, Other Shell Materials 3) By Core Phase: Minerals, Organic Acids, Vitamins, Enzymes, Probiotics, Additives, Essential Oils, Prebiotics, Other Substances, 4) By Application: Dietary Supplements, Functional Food Products, Bakery Products, Confectionery, Beverages, Dairy Products, Other Applications

The term "biosurfactant" refers to a diverse group of molecules, which consist of a polar head (hydrophilic) and a non-polar tail (hydrophobic). They are produced by various microorganisms, which include Acinetobacter sp., Bacillus sp., Candida antartica, and Pseudomonas aeruginosa. They can be used to replace synthetic surfactants in a variety of industrial processes, including lubrication, wetting, softening, fixing dyes, making emulsions, stabilizing dispersions, foaming, and preventing foaming, as well as in the food, biomedical, and pharmaceutical industries, and organic bioremediation. The main types of biosurfactants are glycolipids, phospholipids, surfactin, lichenysin, polymeric biosurfactants, and other product types. The glycolipid surfactants segment consists of sales of glycolipid biosurfactants by entities (organizations, sole traders, and partnerships) that refer to biosurfactants with a structural composition of hydrophilic moieties due to the presence of glucose, mannose, galactose, trehalose, rhamnose, sophorose, and hydrophobic moieties due to the presence of long fatty acid chains. These biosurfactants are synthesized from hydrocarbons, industrial wastes, and frying and olive oil wastes. The biosurfactants are used in detergents, food processing, personal care, agricultural chemicals, and other applications. The biosurfactants market research report is one of a series of new reports from The Business Research Company that provides biosurfactant market statistics, including biosurfactant industry global market size, regional shares, competitors with a biosurfactant market share, detailed biosurfactant market segments, market trends and opportunities, and any further data you may need to thrive in the biosurfactant industry. This biosurfactant market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global biosurfactants market size grew from $4.07 billion in 2022 to $4.39 billion in 2023, at a compound annual growth rate (CAGR) of 7.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The biosurfactants market size is expected to grow to $6 billion in 2027 at a CAGR of 8.1%. The increase in demand for personal care industries across the globe is likely to contribute to the growth of the biosurfactant market in the cosmetic and personal care industries. Biosurfactants are used in the manufacturing of personal care products due to their high biodegradability, low toxicity, multi-functionality, environmental capability, and other factors. Moreover, biosurfactants can be used as wetting agents, solubilizers, dispersants, foaming agents, cleaners, detergents, and emulsion-forming agents. According to the study published by Nielsen Holdings, a USA-based data and market measurement firm, the sales of health, personal care, and beauty products are expected to increase from $53.12 billion in 2019 to $99.12 billion in 2023. Thus, the rapid growth in the personal care sector is expected to boost demand for biosurfactants during the forecast period. Technological development is a key trend gaining popularity in the biosurfactant market. The companies operating in the biosurfactant sector are investing in the development of new biosurfactants to meet the technical demands of different end-use industries across the globe. For instance, in March 2022, Evonik Industries, a Germany-based manufacturer of specialty chemicals, launched Rewoferm RL 100 Biosurfactant to meet the growing demand for low-emission and low-impact cleaning products. Rewoferm RL 100 Biosurfactant is manufactured from locally sourced feedstocks and offers effective cleaning performance. In December 2020, Stepan Company, a USA-based manufacturer of specialty chemicals, acquired Logos Technologies LLC’s NatSurFact business for an undisclosed amount. Through this acquisition, Stepan is planning to build on NatSurFact's work in the next few years to commercialize innovative surfactants and follow their commitment to building sustainable products. NatSurFact is a biosurfactant line based on rhamnolipids. Logos Technologies, LLC, is a technology firm dedicated to providing customers with dependable and innovative solutions. Major players in the biosurfactants market are AGAE Technologies, Croda International plc, Evonik, GlycoSurf, Jeneil, Kemin Industries Inc., Lion Corporation, TensioGreen, Biotensidon, Holiferm, Rhamnolipid, Saraya, Stepan Company, Victex, and Dispersa. Western Europe was the largest region in the biosurfactants market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biosurfactants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the biosurfactants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The biosurfactant market consists of sales of lipopeptides and fatty acids for use as biosurfactants. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global biosurfactants market is segmented - 1) By Product Type: Glycolipids, Phospholipids, Surfactin, Lichenysin, Polymeric Bio-Surfactants, and Other Product Types 2) By Application: Detergents, Personal Care, Food Processing, Agricultural Chemicals, Other Applications

The algae products refer to a class of photosynthetic organisms found in both marine and freshwater habitats and are used in various industries for different purposes. As these organisms have a short doubling time, they are considered among the fastest-growing creatures. Algae are oxygen-exhaling, unicellular, or multicellular microorganisms that consume carbon dioxide and store essential nutrients, minerals, and vitamins. The main types of algae products are lipids, carrageenan, carotenoids, alginate, and algal protein. Algal lipids are extensively used for the production of biofuel. The different forms include liquid, and solid and involve various sources such as blue-green algae, brown algae, green algae, and red algae. These are distributed online, and offline, and are used in food and beverage, nutraceutical and diet supplementation, animal feed, personal care, pharmaceutical, and other applications. The algae products market research report is one of a series of new reports from The Business Research Company that provides algae products market statistics, including algae products industry global market size, regional shares, competitors with a algae products market share, detailed algae products market segments, market trends and opportunities, and any further data you may need to thrive in the algae products industry. This algae products market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global algae products market size grew from $12.12 billion in 2022 to $13.19 billion in 2023 at a compound annual growth rate (CAGR) of 8.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services, and affecting many markets across the globe. The algae products market size is expected to grow to $17.89 billion in 2027 at a CAGR of 7.9%. The growing demand for healthy food products is expected to propel the growth of the algae products market going forward. Healthy food products are those that contain nutrients that support the body's well-being and aid in energy retention. Algae products contain a variety of beneficial elements, including carbohydrates, polyunsaturated fatty acids, essential minerals, and vitamins, which are commonly utilized in healthy foods. For instance, according to BioMed Central (BMC), a UK-based open-access publisher, in 2020 16.7% of the population improved their food behavior by consuming nutritious food which helps in maintaining their immunity, while 34.4% of responders increased their appetite in consumption of nutritious food. Therefore growing demand for healthy food products drives the growth of the algae products market. The development of alternative protein sources such as microalgae is a key trend gaining popularity in the algae products market. Developing alternative protein sources such as microalgae is a crucial step toward achieving the necessary transformation to a more equitable and resilient food system. For instance, in July 2020, Unilever, a UK-based consumer goods company partnered with Algenuity, a UK-based company operating in algae products to develop innovative microalgae products for Unilever’s plant-based portfolio. Algenuity will work with the R&D team within Unilever’s Foods and Refreshment (F&R) division to explore different foods with microalgae. In September 2022, Aliga Microalgae, a Denmark-based food tech, and microalgae producer company acquired Duplaco BV for an undisclosed amount. Through this acquisition, Aliga Microalgae aims to enhance the amount of Chlorella algae products it can produce for the markets for dietary supplements and food additives. Duplaco BV is a Netherland-based producer of fresh Chlorella and microalgae. Major players in the algae products market are BASF SE, Cargill Incorporated, DuPont de Nemours Inc., DSM Nutritional Products AG, EID Parry, Cellana Inc., BlueBioTech Int. GmbH, Corbion NV, Earthrise Nutritionals LLC, Cyanotech Corporation, AlgaeCan Biotech Ltd., Bioprocess Algae LLC, Algenol Biofuels Incorporated, Euglena Co. Ltd., Kerry Group PLC, DIC Corporation, CP Kelco, and Algae Systems LLC. North America was the largest region in the algae products market in 2022. The regions covered in the algae products market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the algae products market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The algae products market consists of sales of bioplastics, industrial lubricants, green chemicals ,cosmetics. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global algae products market is segmented - 1) By Type: Lipids, Carrageenan, Carotenoids, Alginate, Algal Protein 2) By Form: Liquid, Solid 3) By Source: Blue-Green Algae, Brown Algae, Green Algae, Red Algae 4) By Distribution Channel: Online, Offline 5) By Application: Food and Beverage, Nutraceutical and Diet Supplement, Animal Feed, Personal Care, Pharmaceutical, Other Applications

Branded generics refer to an unregistered drug that is marketed under a brand name and provides patients and healthcare providers with a benefit that encourages them to choose the brand. These are the generic medications that have a unique brand name on the market. They might be advertised similarly to how branded medications are. The main drug classes of branded generics are alkylating agents, antimetabolites, hormones, anti-hypertensive, lipid-lowering drugs, anti-depressants, anti-psychotics, anti-epileptics, and other drugs. The alkylating agents of branded generics refer to a subclass of antineoplastic or anticancer medications that work by preventing the conversion of DNA into RNA, which halts the creation of proteins. Alkylating chemicals change the hydrogen atoms on DNA to alkyl groups, which causes cross-links to form inside the DNA chain and has cytotoxic, mutagenic, and cancerous consequences. The various routes of administration of branded generics include topical, oral, parenteral, and other routes. They are in various medical conditions including oncology, cardiovascular diseases, diabetes, neurology, gastrointestinal diseases, dermatology diseases, analgesics and anti-inflammatory, and other diseases. The branded generics market research report is one of a series of new reports from The Business Research Company that provides branded generics market statistics, including branded generics industry global market size, regional shares, competitors with a branded generics market share, detailed branded generics market segments, market trends and opportunities, and any further data you may need to thrive in the branded generics industry. This branded generic market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global branded generics market size grew from $304.16 billion in 2022 to $329.98 billion in 2023 at a compound annual growth rate (CAGR) of 8.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The branded generics market size is expected to grow to $464.58 billion in 2027 at a CAGR of 8.9%. The increasing prevalence of chronic diseases will drive the growth rate of branded generics market. Chronic diseases are long-lasting sicknesses that often cannot be healed, however, they are curable and controllable. Chronic diseases are increasing due to the increasing use of tobacco products, poor nutrition, physical inactivity, excessive use of alcohol, and others. Customers across the globe are more inclined toward branded generics to treat chronic diseases as they purchase them at a lower cost than usual medications. For instance, in September 2020, according to a research report published by American Action Forum, chronic disease prevalence and costs are rising in the United States. They are expected to keep rising as the disease prevalence among children and young adults rises. Chronic disease is a serious healthcare problem since the rising cost of chronic disease in the United States totals $3.7 trillion annually, which is around 19.6% of the country's gross domestic product. Thus an increase in the prevalence of chronic diseases is expected to boost the demand for branded generics during the forecast period. The strategic partnership is a key trend in the branded generics market. The companies operating in branded generics are entering into a partnership with relevant companies to leverage each other's resources and expand into new markets. In December 2021, Biocon Ltd., an India-based fully integrated biopharmaceutical company that develops affordable biosimilars, generic formulations & complex APIs, entered into a partnership with Tabuk Pharmaceuticals. The partnership will open the door for Biocon's entry into the MENA area, which will now include Jordan, Lebanon, Saudi Arabia, the United Arab Emirates, Kuwait, Qatar, Oman, and Iraq. This will help create a robust worldwide portfolio of goods, either directly or through strategic alliances, to provide patients all over the world with access to inexpensive treatments. These medications' marketing authority will be held by Tabuk Pharmaceuticals, which is also in charge of their registration, importation, and promotion in Saudi Arabia and other Middle Eastern nations. Tabuk Pharmaceuticals is a Saudi Arabia-based company that manufactures and markets branded and generic pharmaceutical products. In July 2021, Lupin, an India-based pharmaceutical company offering branded and generic formulations, biosimilars, and active pharmaceutical ingredients (APIs), acquired Southern Cross Pharma Pvt Ltd (SCP) for an undisclosed amount. Through this acquisition, Generic Health, an Australia-based wholly-owned subsidiary of global pharma major Lupin Limited, will have access to more than 60 registered products with approximately USD 22 million in sales. It will result in the growth of value offer and market share of Lupin in the Australian market. Southern Cross Pharma Pvt Ltd (SCP) is an Australia-based pharmaceutical company engaged in developing, registering, and distributing generic products. Major players in the branded generics market are Pfizer Inc., GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd., Mylan N.V., Teva Pharmaceutical Industries Ltd., Sanofi, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Lupin, AstraZeneca, Apotex Inc., Zydus Cadila, Dr. Reddy's Laboratories Ltd., Viatris, Inc., and Valeant Pharmaceuticals International, Inc., North America was the largest region in the branded generics market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the branded generics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the branded generics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The branded generics market consists of sales of glucophage, lopressor, and trimox. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global branded generics market is segmented - 1) By Drug Class: Alkylating Agents, Antimetabolites, Hormones, Anti-hypertensive, Lipid Lowering Drugs, Anti-depressants, Anti-psychotics, Anti-Epileptics, Other Drugs 2) By Route of Administration: Topical, Oral, Parenteral, Other Routes of Administration 3) By Application: Oncology, Cardiovascular Diseases, Diabetes, Neurology, Gastrointestinal Diseases, Dermatology Diseases, Analgesics and Anti-inflammatory, Other Applications